Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma

Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma

10.3390/cancers11101528

Saved in:

Bibliographic Details
Main Authors:	Poh, H.M., Chiou, Y.S., Chong, Q.Y., Chen, R.-M., Rangappa, K.S., Ma, L., Zhu, T., Kumar, A.P., Pandey, V., Basappa, Department of Studies in Organic Chemistry, University of Mysore, Mysore, 570005, India., Lee, S.-C., Lobie, P.E.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	MDPI AG 2021
Subjects:	Acquired resistance Apoptosis Dose-dependent toxicity Doxorubicin Mammary carcinoma PI3K/AKT Trefoil factor 3 (TFF3)
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/209544
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Description
Summary:	10.3390/cancers11101528